Feedback / Questions
Erbitux (cetuximab) - Eli Lilly, EMD Serono
BND-22 - Biond Biologics, Sanofi
Keytruda (pembrolizumab) - Merck (MSD)
https://www.prnewswire.com/news-releases/biond-biologics-announces-first-patients-dosed-with-bnd-22-sar444881-combinations-in-phase-1-clinical-trial-301552737.html
May 23, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next